CDK18 and breast cancer: From 162 studies representing over 45,000 samples, CDK18 gene amplification (due to copy number variance gain) was vastly more prevalent than deletions or mutations, with 4 out of the top 5 incidences of reported CDK18 amplification occurring in breast cancer cohorts (Figure 1A).